Arcturus Therapeutics Holdings (ARCT) Times Interest Earned (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) posted Times Interest Earned of -$1.05 for Q1 2026, down 379.14% on a QoQ basis from -$0.22 in Q4 2025, and down 102.28% year-over-year from $45.87 in Q1 2025.
Arcturus Therapeutics Holdings (ARCT) Times Interest Earned (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings' Times Interest Earned history runs 9 years deep, the most recent figure standing at -$1.05 for Q1 2026.
- Quarterly Times Interest Earned fell 102.28% year-over-year to -$1.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.19 (down 26.65% YoY) and the FY2025 annual result came in at -$0.53, up 23.33% from the prior year.
- Times Interest Earned was -$1.05 for Q1 2026 at Arcturus Therapeutics Holdings, down from -$0.22 in the prior quarter.
- Across five years, Times Interest Earned topped out at $532.68 in Q4 2022 and bottomed at -$730.88 in Q4 2023.
- A 5-year average of -$13.03 and a median of -$0.55 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 340.55% — and 2024, when it sank 344.53%.
- Arcturus Therapeutics Holdings' Times Interest Earned stood at $532.68 in 2022, then tumbled by 237.21% to -$730.88 in 2023, then surged by 99.97% to -$0.24 in 2024, then gained by 9.83% to -$0.22 in 2025, then plunged by 379.14% to -$1.05 in 2026.
- Business Quant data shows ARCT's Times Interest Earned at -$1.05 in Q1 2026, -$0.22 in Q4 2025, and -$0.55 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - | -1.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.05 |
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -0.55 |
| Jun 30, 2025 | -3.04 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -3.55 |
| Mar 31, 2024 | -4.80 |
| Dec 31, 2023 | -730.88 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -1.41 |
| Mar 31, 2023 | 1.96 |
| Dec 31, 2022 | 532.68 |
| Sep 30, 2022 | -0.85 |
| Jun 30, 2022 | -0.50 |
| Mar 31, 2022 | -7.76 |
| Dec 31, 2021 | -221.44 |
| Sep 30, 2021 | -7.22 |
| Jun 30, 2021 | -6.74 |